Issue

Vol. 26 No. 23 (2014)

Copyright (c) 2014 Lütfi Genç1

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Bioconjugates and Nanocarriers for Therapy, Imaging, Drug Design and Targeting: A Review

https://doi.org/10.14233/ajchem.2014.17952
Lütfi Genç1
1Anadolu University, Plant, Drug and Scientific Research Center (AUBIBAM), Tepebasi 26470, Eskisehir, Turkey 2Department of Pharmaceutical Technology, Faculty of Pharmacy, Anadolu University, Tepebasi 26470, Eskisehir, Turkey *Corresponding author: Tel: +90 536 8672202; E-mail: lgenc@anadolu.edu.tr

Corresponding Author(s) : Lütfi Genç1

Asian Journal of Chemistry, Vol. 26 No. 23 (2014)

Abstract

Currently, bioconjugates and nanocarriers can be practically used in drug discovery, therapy, diagnosis, imaging, targeting, stability, etc. Also preparing nano drug carrier systems (NDCSs) is a common application of bio-conjugates. Current examples of bio-conjugates are nanoparticles, liposomes, micelles, dendrimers, quantum dots, carbon nanotubes, nano-fibers, but not limited to. As bioconjugates, nano drug carrier systems have important roles in the development of intelligent drugs such as tailor made drugs and drug targeting systems for early diagnosis steps and therapy. Currently, different drug carrier systems can be designed for improvement of the physico-chemical properties of drugs, controlling drug release, stability, in vivo performance and modification of the surface chemistry of drugs by using nanotechnology, bioconjugation and PEGylation. The anticancer efficacy of existing chemotherapeutic drugs can be improved by employing formulation, bioconjugation and nano-technological approaches. This current review focuses on the description of bioconjugates and nano drug carrier systems for diagnosis, imaging and therapy reported mainly in the last decade.

Keywords

Bioconjugates Nano drug carrier systems PEGylation Drug targeting Anticancer efficacy Diagnosis Imaging Therapy.
Genç1, L. (2014). Bioconjugates and Nanocarriers for Therapy, Imaging, Drug Design and Targeting: A Review. Asian Journal of Chemistry, 26(23), 7887–7892. https://doi.org/10.14233/ajchem.2014.17952
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. G.T. Hermanson, Bioconjugate Techniques, Academic Press, Elsevier, edn. 3, pp. 1-125, 787-838 (2013).
  2. S. Salmaso, S. Bersani, A. Scomparin, F. Mastrotto and P. Caliceti, Isr. J. Chem., 50, 160 (2010).
  3. L. Genç, Asian Chem. Lett., 16, 37 (2011).
  4. D.J. Bharali, M. Khalil, M. Gurbuz, T.M. Simone and S.A. Mousa, Int. J. Nanomedicine, 4, 1 (2009).
  5. N.R. Jabir, S. Tabrez and G. Md Ashraf, Int. J. Nanomedicine, 7, 4391 (2012).
  6. G. Güney, L. Genç and G. Dikmen, J. Mater. Sci. Eng., 5, 577 (2011).
  7. A.S. Hoffman and P.S. Stayton, Macromol. Symp., 207, 139 (2004).
  8. S. Abramkin, S.M. Valiahdi, M.J. Jakupec, M. Galanski, N. Metzler-Nolte and B.K. Keppler, Dalton Trans., 41, 3001 (2012).
  9. A.I. Eroglu, Y.B. Kilinc and Z. Mustafaeva, Turkish J. Biochem., 36, 22 (2011).
  10. S.I. Kirin, I. Ott, R. Gust, W. Mier, T. Weyhermüller and N. Metzler-Nolte, Angew. Chem. Int. Ed., 47, 955 (2008).
  11. A.K. Petrus, T.J. Fairchild and R.P. Doyle, Angew. Chem. Int. Ed., 48, 1022 (2009).
  12. S.M. Clardy, D.G. Allis, T.J. Fairchild and R.P. Doyle, Expert Opin. Drug Deliv., 8, 127 (2011).
  13. F.-L. Mi, Y.-Y. Wu, Y.-H. Lin, K. Sonaje, Y.-C. Ho, C.-T. Chen, J.-H. Juang and H.-W. Sung, Bioconjug. Chem., 19, 1248 (2008).
  14. O.C. Farokhzad, J.M. Karp and J. Langer, Expert Opin. Drug Deliv., 3, 311 (2006).
  15. O.C. Farokhzad, J. Cheng, B.A. Teply, I. Sherifi, S. Jon, P.W. Kantoff, J.P. Richie and R. Langer, Proc. Natl. Acad. Sci. USA, 103, 6315 (2006).
  16. S. Salmaso, S. Bersani, A. Semenzato and P. Caliceti, J. Drug Target., 15, 379 (2007).
  17. D. Kim, Y.Y. Jeong and S. Jon, ACS Nano, 4, 3689 (2010).
  18. K.T. Oh, H. Yin, E.S. Lee and Y.H. Bae, J. Mater. Chem., 17, 3987 (2007).
  19. R. Xu, M. Fisher and R.L. Juliano, Bioconjug. Chem., 22, 870 (2011).
  20. P. Caliceti, S. Salmaso, A. Semenzato, T. Carofiglio, R. Fornasier, M. Fermeglia, M. Ferrone and S. Pricl, Bioconjug. Chem., 14, 899 (2003).
  21. E.S. Gil and S.M. Hudson, Prog. Polym. Sci., 29, 1173 (2004).
  22. S. Tsunoda, H. Kamada, Y. Yamamoto, T. Ishikawa, J. Matsui, K. Koizumi, Y. Kaneda, Y. Tsutsumi, Y. Ohsugi, T. Hirano and T. Mayumi, J. Control. Rel., 68, 335 (2000).
  23. D. Chandrasekar, R. Sistla, F.J. Ahmad, R.K. Khar and P.V. Diwan, Biomaterials, 28, 504 (2007).
  24. P. Meng, W.E. Hennink and Z. Zhong, Biomaterials, 30, 2180 (2009).
  25. H.M. Kutlu, L. Genç and G. Güney, Curr. Nanosci., 9, 698 (2013).
  26. L. Genç and M. Demirel, Pharm. Dev. Technol., 18, 701 (2013).
  27. L. Genç, G. Dikmen and G. Güney, J. Mater. Sci. Eng., 1, 429 (2011).
  28. V. Biju, S. Mundayoor, R.V. Omkumar, A. Anas and M. Ishikawa, Biotechnol. Adv., 28, 199 (2010).
  29. A.M. Smith, H. Duan, A. Mohs and S. Nie, Adv. Drug Deliv. Rev., 60, 1226 (2008).
  30. S.N.S. Alconcel, A.S. Baas and H.D. Maynard, Polymer Chem., 2, 1442 (2011).
  31. F.M. Veronese and G. Pasut, Drug Discov. Today, 10, 1451 (2005).
  32. R.B. Greenwald, Y.H. Choe, J. McGuire and C.D .Conover, Adv. Drug Deliv. Rev., 55, 217 (2003).
  33. P. Calvo, B. Gouritin, H. Chacun, D. Desmaële, J.D’Angelo, J.-P. Noel, D. Georgin, E. Fattal, J.P. Andreux and P. Couvreur, Pharm. Res., 18, 1157 (2001).
  34. Z. Liu, J.T. Robinson, X. Sun and H. Dai, J. Am. Chem. Soc., 130, 10876 (2008).
  35. Y. Kaneda, Y. Tsutsumi, Y. Yoshioka, H. Kamada, Y. Yamamoto, H. Kodaira, S. Tsunoda, T. Okamoto, Y. Mukai, H. Shibata, S. Nakagawa and T. Mayumi, Biomaterials, 25, 3259 (2004).
  36. J. Wang, H. Qu, L. Jin, W. Zeng, L. Qin, F. Zhang, X. Wei, W. Lu, C. Zhang and W. Liang, J. Pharm. Sci., 100, 2267 (2011).
  37. K.R. Reddy, Ann. Pharmacother., 34, 915 (2000).
  38. J. Park, P.M. Fong, J. Lu, K.S. Russell, C.J. Booth, W.M. Saltzman and T.M. Fahmy, Nanomedicine, 5, 410 (2009).
  39. Q. He, J. Zhang, J. Shi, Z. Zhu, L. Zhang, W. Bu, L. Guo and Y. Chen, Biomaterials, 31, 1085 (2010).
  40. I. Ozcan, Freimar Segura-Sanchez, KawtharBouchemal, Murat Sezak, ÖzgenÖzer, Tamer Güneri, Gilles Ponchel and Gilles Ponchel, Int. J. Nanomedicine, 5, 1103 (2010).
  41. J. Suh, K.-L. Choy, S.K. Lai, J.S. Suk, B.C. Tang, S. Prabhuand and J. Hanes, Int. J. Nanomedicine, 2, 735 (2007).
  42. H. Otsuka, Y. Nagasaki and K. Kataoka, Adv. Drug Deliv. Rev., 55, 403 (2003).
  43. J.V. Jokerst, T. Lobovkina, R.N. Zare and S.S. Gambhir, Nanomedicine, 6, 715 (2011).
  44. D. Thassu, M. Deleers and Y. Pathak, Nanoparticulate Drug Delivery Systems, Informa Healthcare, Inc. 270 Madison Avenue, New York, USA, Section 3. S.S. Chakravarthi and D.H. Robinson, Nanoparticles Prepared Using Natural and Synthetic Polymers, pp. 51-60 (2007).
  45. M.M. Villers, P. Aramwit and G.S. Kwon, Nanotechnology in Drug Delivery, Springer Sciences and Business Media, New York, USA, pp. 1-163 (2009).
  46. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit and R. Langer, Nat. Nanotechnol., 2, 751 (2007).
  47. M. Ferrari and V. Torchilin, Fundamental Biomedical Technologies-Multifunctional Pharmaceutical Nanocarriers, Springer Sciences and Business Media, LLC, USA, Section 1: V.P. Torchilin, Multifunctional Pharmaceutical Nanocarriers: Development of the Concept, Edit., pp. 1-32 (2008).
  48. A. Bianco, K. Kostarelos and M. Prato, Curr. Opin. Chem. Biol., 9, 674 (2005).
  49. M.M. Villers, P. Aramwit and G.S. Kwon, Nanotechnology in Drug Delivery, Springer Sciences and Business Media, LLC, New York, USA, Section 8: S.T. Zuckerman and W.J. Kao, Nanomaterials and Biocom-patibility: Carbon Nanotubes and Fullerenes, pp. 229-266 (2009).
  50. I.T. Degim, D.J. Burgess and F. Papadimitrakopoulos, J. Microencapsul., 27, 669 (2010).
  51. S. Ilbasmis-Tamer, S. Yilmaz, E. Banoglu and I.T. Degim, J. Biomed. Nanotechnol., 6, 20 (2010).
  52. R. Esfand and D.A. Tomalia, Drug Discov. Today, 6, 427 (2001).
  53. P. Vijayaraj Kumar, H. Agashe, T. Dutta and N. Jain, Curr. Drug Deliv., 4, 11 (2007).
  54. J.M. Oliveira, A.J. Salgado, N. Sousa, J.F. Mano and R.L. Reis, Prog. Polym. Sci., 35, 1163 (2010).
  55. D.A. Tomalia, L.A. Reyna and S. Svenson, Biochem. Soc. Trans., 35, 61 (2007).
  56. G.P. Mishra, M. Bagui, V. Tamboli, A.K. Mitra, J. Drug Deliv., Article ID 863734 (2011).
  57. S. Jain, N. Jain, D. Bhadra, A.K. Tiwary and N.K. Jain, Curr. Drug Deliv., 2, 223 (2005).
  58. H. Brochu, A. Polidori, B. Pucci and P. Vermette, Curr. Drug Deliv., 1, 299 (2004).
  59. E.C. Ramsay, N.D. Santos, W.H. Dragowska, J.J. Laskin and M.B. Bally, Curr. Drug Deliv., 2, 341 (2005).
  60. P. Sapra, P. Tyagi and T.M. Allen, Curr. Drug Deliv., 2, 369 (2005).
  61. A. Samad, Y. Sultana and M. Aqil, Curr. Drug Deliv., 4, 297 (2007).
  62. V.P. Torchilin, Nanoparticulates as Drug Carriers, Imperial College Press 57 Shelton Street Covent Garden London WCH2H 9HE, UK, Section 5: A.V. Batrakova, T.K. Bronich, J.A. Vetro and A.V. Kabanov, Polymer Micelles as Drug Carriers, pp. 57-93 (2006).
  63. N. Nishiyama and K. Kataoka, Pharmacol. Ther., 112, 630 (2006).
  64. V.P. Torchilin, Nanoparticulates as Drug Carriers, Imperial College Press 57 Shelton Street Covent Garden London WCH2H 9HE,UK, Section 3: S.M. Moghimi, E. Vega, M.L. Garcia, O.A.R. Al-Hanbali and K.J. Rutt, Polymeric Nanoparticles as Drug Carriers and Controlled Release Implant Devices, pp. 29-42 (2006).
  65. E.M. Del Amo and A. Urtti, Drug Discov. Today, 13, 135 (2008).
  66. M.M. Bailey and C.J. Berkland, Med. Res. Rev., 29, 196 (2009).
  67. M. Diwan, P. Elamanchili, M. Cao and J. Samuel, Curr. Drug Deliv., 1, 405 (2004).
  68. M. Tao Liang, N. Davies, J. Blanchfield and I. Toth, Curr. Drug Deliv., 3, 379 (2006).
  69. Y. Hattori and Y. Maitani, Curr. Drug Deliv., 2, 243 (2005).
  70. C. Vauthier and K. Bouchemal, Pharm. Res., 26, 1025 (2009).
  71. A. Hoshino, K. Hanaki, K. Suzuki and K. Yamamoto, Biochem. Biophys. Res. Commun., 314, 46 (2004).
  72. D. Maysinger, J. Lovric, A. Eisenberg and R. Savic, Eur. J. Pharm. Biopharm., 65, 270 (2007).
  73. X. Gao and S. Nie, Trends Biotechnol., 21, 371 (2003).
  74. W.C.W. Chan, D.J. Maxwell, X. Gao, R.E. Bailey, M. Han and S. Nie, Curr. Opin. Biotechnol., 13, 40 (2002).
  75. W.A. Hild, M. Breunig and A. Goepferich, Eur. J. Pharm. Biopharm., 68, 153 (2008).
  76. J.E. Schroeder, I. Shweky, H. Shmeeda, U. Banin and A. Gabizon, J. Control. Rel., 124, 28 (2007).
  77. H.M.E. Azzazy, M.M.H. Mansour and S.C. Kazmierczak, Clin. Biochem., 40, 917 (2007).
  78. J. Pan and S.S. Feng, Biomaterials, 30, 1176 (2009).
  79. V.P. Torchilin, Nanoparticulates as Drug Carriers, Imperial College Press 57 Shelton Street Covent Garden London WCH2H 9HE, UK, Section 9: K. Mader, Solid Lipid Nanoparticles as Drug Carriers, pp. 187-212 (2006).
  80. D. Thassu, M. Deleers and Y. Pathak, Nanoparticulate Drug Delivery Systems, Informa Healthcare, Inc. 270 Madison Avenue, New York, USA, Section 14: E.B. Souto and R.H. Müller, Lipid nanoparticles (SLN and Nanoctructured Lipid Carriers) for Cosmetic, Dermal and Transdermal Applications, pp. 213-233 (2007).
  81. M.R. Mozafari, Nanocarrier Technologies: Frontiers of Nanotheraphy, Solid lipid nanoparticles, pp. 41-50 (2006).
  82. M. Trotta, F. Debernardi and O. Caputo, Int. J. Pharm., 257, 153 (2003).
  83. J. You, F. Wan, F. Decui, Y. Sun, Y. Du and F. Hu, Int. J. Pharm., 343, 270 (2007).
  84. C. Charcosset, A. El-Harati and H. Fessi, J. Control. Release, 108, 112 (2005).
  85. N.A. ALHaj, R. Abdullah, S. Ibrahim and A. Bustamam, Am. J. Pharmacol. Toxicol., 3, 219 (2008).
  86. M. Üner and G. Yener, Int. J. Nanomedicine, 2, 289 (2007).
  87. A.J. Almeida and E. Souto, Adv. Drug Deliv. Rev., 59, 478 (2007).
  88. R.H. Müller, K. Mader and S. Gohla, Eur. J. Pharm. Biopharm., 50, 161 (2000).
  89. P. Blasi, S. Giovagnoli, A. Schoubben, M. Ricci and C. Rossi, Adv. Drug Deliv. Rev., 59, 454 (2007).
  90. M.-K. Lee, S.-J. Lim and C.-K. Kim, Biomaterials, 28, 2137 (2007).
  91. M. Üner, Pharmazie, 61, 375 (2006).
Read More
Author biographies is not available.
Download
Statistic
Read Counter : 0